Beate Lichtenberger, PhD of the Medical University of Vienna, Vienna, Austria, provides an insight into the new research that is…
Browsing: Acute Lymphoblastic Leukemia
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on vemurafenib and cobimetinib…
Petr Arenberger, MD, PhD, DSc, MBA of Charles University, Prague, Czech Republic discusses skin cancer in Central Europe at the…
Nikolas Haass, MD, PhD of the University of Queensland, Brisbane, Australia discusses cell cycle-dependent drug resistance or sensitivity in melanoma.…
Marius Erik Mayerhöfer, MD, PhD of the Medical University of Vienna, Vienna, Austria discusses changes in the imaging methods used…
Herbert Hönigsmann, MD of the Medical University of Vienna, Vienna, Austria discusses issues in the use of sun protection by…
Isaac Brownell, MD, PhD of the National Cancer Institute, Bethesda, MD gives an overview of his talk on new treatment…
Herbert Hönigsmann, MD of the Medical University of Vienna, Vienna, Austria outlines his talk sun protection held at the World…
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discusses his talk on vaccines for melanoma held at the 2016…
Eva Lehner-Baumgartner, PhD, of the Medical University of Vienna, Vienna, gives an overview of her talk on strategies to support…
Dirk Schadendorf, MD of University Hospital Essen, Essen, Germany gives an overview of his talk on kinase inhibitors in rare…
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, discusses his work on BRAF inhibition in melanoma. 50% of melanomas…
Beate Lichtenberger, PhD of the Medical University of Vienna, Vienna, Austria, discusses the role of fibroblasts in cutaneous carcionogenesis. Dr…
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on dabrafenib and trametinib…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Marcello Deraco discusses the treatment of surgically-resectable…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Harpreet Wasan argues that radio- or chemoembolization…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Phillipe Rouanet discusses whether or not robotic…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Heinz-Josef Lenz discusses whether tumor location is…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Aimery de Gramont discusses how to improve…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Takayuki Yoshino presents Asian guidelines for the…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Axel Grothey presents the NCCN guidelines for…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Van Cutsem discusses the ESMO guidelines…
In this Keynote Lecture, Dr. Paul Cornes discusses health economics and cost from both the physician’s and payer’s perspective, with…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Roberto Labianca presents highlights of the poster…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Ramon Salazar examines whether gene signatures are…
How to improve the diagnosis of stage III colon cancer?
This video is the study background of a collaborative Cleveland Clinic-Mayo Clinic team of researchers has shown for the first…
What does MPN (myeloproliferative neoplasm) mean? How has the MPN field changed in recent years? Patient Power Host and MPN…
Are stem cell transplants an effective treatment for patients with multiple myeloma (MM)? Myeloma expert Dr. Gareth Morgan of UAMS…
According to a new study, African-American women who participate in vigorous exercise had a 12% lower risk of receiving a…
Dr. Andrei Gudkov, Senior Vice President for Basic Science at Roswell Park Cancer Institute in Buffalo, NY shares findings from…
New research, co-authored by James Mohler, MD, Chair of the Department of Urology at Roswell Park Cancer Institute, reveals that…
David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses end-of-life decisions, which should be based on patients…
David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses hydration and nutrition in end-of-life patients. Hydration is…
In this Keynote Lecture, Dr. Scott Kopetz discusses the BRAF pathway in colorectal cancer (CRC).
In this Keynote Lecture, Dr. Aurélien Marabelle discusses the relevant immune mechanisms in GI cancer.
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Drs. Andrés Cervantes and Karin Haustermans examine two…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Julio Garcia-Aguilar discusses the advances and challenges…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Andre D’Hoore discusses how to best to…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Gina Brown argues that MRI is mandatory…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Monique Van Leerdam discusses the image of…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Nadir Arber discusses whether or not advanced…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Judith Balmaña discusses hereditary colon and gastric…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Raymond discusses new targets and agents…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Chris Verslype arguest for the locoregional treatment…
Developing a therapeutic algorithm in small bowel NETs
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN discusses the use of olanzapine for nausea control in chemotherapy-treated patients. Data…
How do you choose the best treatment options for YOUR multiple myeloma (MM)? With more multiple myeloma treatments being approved…
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN discusses treatment options for patients with established neuropathy. If a chemotherapy treatment…